Prostate Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer
Recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • Bangalore, India
  • +6 more
2021-12-02
Dec 2, 2021
B
Study of Nivolumab Plus Ipilimumab, Ipilimumab or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Nivolumab
  • +3 more
  • Tucson, Arizona
  • +59 more
2021-12-01
Dec 1, 2021
M
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Recruiting
  • Prostate Cancer
  • Charleston, South Carolina
    Medical University of South Carolina
2021-12-02
Dec 2, 2021
N
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Not yet recruiting
  • Prostate Cancer
  • mpMRI
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-02
Dec 2, 2021
B
68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical
Active, not recruiting
  • Prostate Cancer
  • +5 more
  • [68Ga]Ga-HTK03149 PET/CT
  • Vancouver, British Columbia, Canada
    BC Cancer
2021-12-01
Dec 1, 2021
N
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
Not yet recruiting
  • Prostate Cancer
  • TULSA-PRO
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-02
Dec 2, 2021
J
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen
Active, not recruiting
Has Results
  • Prostate Cancer
  • Prostatic Neoplasm
  • abiraterone acetate in combination with prednisone
  • Homewood, Alabama
  • +44 more
2021-12-02
Dec 2, 2021
U
Proton Therapy for Low and Intermediate Risk Prostate Cancer
Active, not recruiting
Has Results
  • Prostate Cancer
  • Low Risk Proton Radiation
  • Intermediate Risk Proton Radiation
  • Jacksonville, Florida
    University of Florida Proton Therapy Institute
2021-12-01
Dec 1, 2021
A
Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate
Active, not recruiting
  • Prostate Cancer
  • Boston, Massachusetts
    (unnamed)
2021-12-02
Dec 2, 2021
A
Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)
Active, not recruiting
Has Results
  • Prostate Cancer
  • ARN-509 (Phase 1)
  • ARN-509 (Phase 2)
  • San Diego, California
  • +14 more
2021-12-02
Dec 2, 2021
U
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Active, not recruiting
Has Results
  • Prostate Cancer
  • < 15% risk of + LN
  • > 15% risk of + LN
  • Jacksonville, Florida
    University of Florida Proton Therapy Institute
2021-12-01
Dec 1, 2021
M
SBRT for Oligometastatic Castration-Refractory Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • SBRT
  • Rochester, Minnesota
    Mayo Clinic
2021-11-30
Nov 30, 2021
I
Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy
Not yet recruiting
  • Prostate Cancer
  • Healthy Donors
  • Urine sampling
  • Paris, France
    Institut Curie
2021-11-19
Nov 19, 2021
U
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
Recruiting
  • Prostate Cancer
  • PSMA-1007 Positron Emission Tomography (PET) scan and 3T Magnetic Resonance Imaging (MRI)
  • Edmonton, Alberta, Canada
    University of Alberta
2021-11-18
Nov 18, 2021
W
Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer
Not yet recruiting
  • Prostate Cancer
  • Cancer of Prostate
  • Saint Louis, Missouri
    Washington University School of Medicine
2021-11-19
Nov 19, 2021
E
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Scottsdale, Arizona
  • +87 more
2021-12-01
Dec 1, 2021
A
An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer
Active, not recruiting
  • Prostate Cancer
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Denver, Colorado
  • +8 more
2021-11-29
Nov 29, 2021
N
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Recruiting
  • Prostatic Neoplasms
  • Prostate Cancer
  • Nimes Cedex 9, France
  • +5 more
2021-12-01
Dec 1, 2021
L
Aberrant Gene Expression Prostate Carcinoma
Active, not recruiting
  • Prostate Cancer
    • Burlington, Massachusetts
      Lahey Clinic
    2021-12-01
    Dec 1, 2021
    S
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    Active, not recruiting
    Has Results
    • Prostate Cancer
    • Jonesboro, Arkansas
    • +204 more
    2021-11-29
    Nov 29, 2021
    N
    Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
    Active, not recruiting
    • Melanoma
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2021-12-01
      Dec 1, 2021
      L
      Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®
      Active, not recruiting
      • Prostate Cancer
      • Guangzhou, China
        Sun Yat-sen Memorial Hospital of Sun Yat-sen University
      2021-11-19
      Nov 19, 2021
      A
      A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
      Recruiting
      • Prostate Cancer
      • Anchorage, Alaska
      • +121 more
      2021-11-29
      Nov 29, 2021
      A
      Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC
      Recruiting
      • Metastatic Castration-resistant Prostate Cancer
      • Prostate Cancer
      • Duarte, California
      • +28 more
      2021-11-30
      Nov 30, 2021
      A
      'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
      Recruiting
      • Ovarian Cancer
      • +3 more
        • Busan, Korea, Republic of
        • +8 more
        2021-11-18
        Nov 18, 2021